Ferreira, M A D <br/><br/>
Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.  [electronic resource] 

 -  British journal of pharmacology  Jul 2008 
 - 1216-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/bjp.2008.199  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate--pharmacology<br/>Adenosine Triphosphate--metabolism<br/>Adolescent<br/>Adult<br/>Anthraquinones--isolation & purification<br/>Blood Platelets--drug effects<br/>Cyclic AMP--biosynthesis<br/>Cyclic GMP--blood<br/>Cyclic Nucleotide Phosphodiesterases, Type 5--blood<br/>Female<br/>Flow Cytometry<br/>Guanylate Cyclase--blood<br/>Humans<br/>In Vitro Techniques<br/>Male<br/>Middle Aged<br/>Nitric Oxide--metabolism<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--metabolism<br/>Platelet Glycoprotein GPIb-IX Complex--metabolism<br/>Protein Binding<br/>Thromboxane A2--physiology